These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Drug-eluting vs. bare metal stents for symptomatic vertebral artery stenosis. Song L; Li J; Gu Y; Yu H; Chen B; Guo L; Zhang J J Endovasc Ther; 2012 Apr; 19(2):231-8. PubMed ID: 22545889 [TBL] [Abstract][Full Text] [Related]
8. Percutaneous intervention for posterior fossa ischemia. A single center experience and review of the literature. Zavala-Alarcon E; Emmans L; Little R; Bant A Int J Cardiol; 2008 Jun; 127(1):70-7. PubMed ID: 17651834 [TBL] [Abstract][Full Text] [Related]
9. Treatment of intracranial atherosclerotic disease with a balloon-expandable paclitaxel eluting stent: procedural safety, efficacy and mid-term patency. Vajda Z; Aguilar M; Göhringer T; Horváth-Rizea D; Bäzner H; Henkes H Clin Neuroradiol; 2012 Sep; 22(3):227-33. PubMed ID: 22252289 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of stent angioplasty for symptomatic stenoses of the proximal vertebral artery. Weber W; Mayer TE; Henkes H; Kis B; Hamann GF; Holtmannspoetter M; Brueckmann H; Kuehne D Eur J Radiol; 2005 Nov; 56(2):240-7. PubMed ID: 15961267 [TBL] [Abstract][Full Text] [Related]
11. Percutaneous vertebral artery intervention: a necessary tool in every interventional cardiologist armamentarium. Zavala-Alarcon E; Emmans L; Cecena F; Little R; Bant A Cardiovasc Revasc Med; 2007; 8(2):107-13. PubMed ID: 17574170 [TBL] [Abstract][Full Text] [Related]
12. [Percutaneous interventional treatment of vertebral artery stenosis with coronary stents: two case reports]. Inoue F; Tsuzuki T; Thoma Y; Shiono S; Tabuse H; Hoshida T; Saito Y J Cardiol; 2006 Jul; 48(1):51-7. PubMed ID: 16886499 [TBL] [Abstract][Full Text] [Related]
13. Drug-eluting stent for the treatment of symptomatic vertebral origin stenosis: Long-term results. Chen X; Huang Q; Hong B; Zhang Y; Xu Y; Liu J J Clin Neurosci; 2011 Jan; 18(1):47-51. PubMed ID: 20888236 [TBL] [Abstract][Full Text] [Related]
14. Stent fracture in revascularization for symptomatic ostial vertebral artery stenosis. Tsutsumi M; Kazekawa K; Onizuka M; Kodama T; Matsubara S; Aikawa H; Iko M; Nii K; Etou H; Tanaka A Neuroradiology; 2007 Mar; 49(3):253-7. PubMed ID: 17151868 [TBL] [Abstract][Full Text] [Related]
15. Restenosis rates following vertebral artery origin stenting: does stent type make a difference? Ogilvy CS; Yang X; Natarajan SK; Hauck EF; Sun L; Lewis-Mason L; Hopkins LN; Siddiqui AH; Levy EI J Invasive Cardiol; 2010 Mar; 22(3):119-24. PubMed ID: 20197579 [TBL] [Abstract][Full Text] [Related]
16. Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Gupta R; Al-Ali F; Thomas AJ; Horowitz MB; Barrow T; Vora NA; Uchino K; Hammer MD; Wechsler LR; Jovin TG Stroke; 2006 Oct; 37(10):2562-6. PubMed ID: 16960090 [TBL] [Abstract][Full Text] [Related]
17. Long-Term Risk of In-Stent Restenosis and Stent Fracture for Extracranial Vertebral Artery Stenting. Li MKA; Tsang ACO; Tsang FCP; Ho WS; Lee R; Leung GKK; Lui WM Clin Neuroradiol; 2019 Dec; 29(4):701-706. PubMed ID: 30039353 [TBL] [Abstract][Full Text] [Related]
18. Drug-eluting stents for the treatment of vertebral artery origin stenosis. Werner M; Bräunlich S; Ulrich M; Bausback Y; Schuster J; Lukhaup A; Botsios S; Scheinert D; Schmidt A J Endovasc Ther; 2010 Apr; 17(2):232-40. PubMed ID: 20426646 [TBL] [Abstract][Full Text] [Related]
19. Endovascular treatment of supra-aortic extracranial stenoses in patients with vertebrobasilar insufficiency symptoms. Zaytsev AY; Stoyda AY; Smirnov VE; Scherbyuk AN; Kondrashin SA; Artukchina EG; Kikevitch VA Cardiovasc Intervent Radiol; 2006; 29(5):731-8. PubMed ID: 16718428 [TBL] [Abstract][Full Text] [Related]